Panel Discussion | Novel Targets in Development for IgA Nephropathy: Where are the Current Late Phase Trials Heading?

Time: 11:00 am
day: Pre-Conference Seminar Day


  • From complement to APRIL to ETA: what targets are currently in development and looking most promising?
  • Exploring new treatment possibilities with combinational targeting
  • Exploring the current thinking on IgA pathogenesis to direct priorities for future target development